Full Interview: Algernon Pharmaceuticals Announces Regulatory Submission for COVID-19 Trial in South Korea

Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive Vancouver to discuss another development for their repurposed drug Ifenprodil. Moreau provides an update about the clinical study which will consist of 40 patients and will deal with those currently sick with COVID-19.